Brief: Propanc Biopharma Implements Reverse Stock Split To Support Continued Nasdaq Listing And Growth Plans
14/05/2026 03:00
May 13 (Reuters) - Propanc Biopharma Inc PPCB.O: PROPANC BIOPHARMA IMPLEMENTS REVERSE STOCK SPLIT TO SUPPORT CONTINUED NASDAQ LISTING AND GROWTH PLANS PROPANC BIOPHARMA INC - APPROVES 1-FOR-25 REVERSE STOCK SPLIT EFFECTIVE MAY 18, 2026 Source text: ID:nGNX38YJxk Further company coverage: PPCB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Propanc Biopharma
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition With Prp In Pancreatic Cancer Models, Contrasting Profile With Revolution Medicines’ Daraxonrasib
Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing
Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients